StemPrintER Risk Score (SPRS) is an alternative genomic predictor based on the biology of cancer ste17 Aug 2020 09:58
Morning all
I am not sure if this info has been posted on here so p[osting now. For anyone that requires proof that StemPrintER is far better than the current standard test using OncotypeDX read and be informed !!!
Authors:
Salvatore Pece, Ivana Sestak, Francesca Montani, Micol Tillhon, Stefano Freddi, Patrick Maisonneuve, Marco Colleoni, Paolo Veronesi, Davide Disalvatore, Giuseppe Viale, Richard Buus, Jack M. Cuzick, Mitchell Dowsett, Pier Paolo Di Fiore; European Institute of Oncology, Milan, Italy; Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom; Istituto Europeo di Oncologia, Milan, Italy; European Institute of Oncology, IRCCS, Milan, Italy; Division of Medical Senology, IEO, European Institute of Oncology IRCCS, Milan, Italy; Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy; Division of Pathology, European Institute of Oncology, IRCCS, Milan, Italy; The Institute of Cancer Research, London, United Kingdom; Wolfson Institute of Preventive Medicine, London, United Kingdom; The Royal Marsden NHS Foundation Trust, London, United Kingdom
go to link
https://meetinglibrary.asco.org/record/185144/abstract